Spero Therapeutics, Inc. Public Float
Spero Therapeutics, Inc. (SPRO) had Public Float of $160.30 million as of 2025-06-30, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-26
- 2025-06-30: Entity Public Float $160.30M.
- 2024-06-28: Entity Public Float $69.50M.
- 2023-06-30: Entity Public Float $76.00M.
- 2022-12-31: Entity Public Float $22.00M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $160.30M 10-K · filed 2026-03-26 |
| 2024-06-28 | $69.50M 10-K · filed 2025-03-27 |
| 2023-06-30 | $76.00M 10-K · filed 2024-03-13 |
| 2022-12-31 | $22.00M 10-K · filed 2023-03-30 |
| 2021-06-30 | $326.30M 10-K · filed 2022-03-31 |
| 2020-06-30 | $256.20M 10-K · filed 2021-03-11 |
| 2019-06-28 | $150.50M 10-K · filed 2020-03-16 |
| 2018-06-29 | $210.90M 10-K · filed 2019-03-14 |
| 2017-06-30 | $0.00 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |